Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	20.24	57.82	48.09
Graham Fair Price	-29.89	37.68	53.75
PEG	239.24	-0.25	0.07
Price/Book	20.98	0.79	0.65
Price/Cash Flow	-119.77	-12.39	-5.64
Prices/Earnings	150.41	13.19	5.27
Price/Sales	32.00	8.58	6.50
Price/FCF	-119.77	-12.39	-5.64
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.42	0.31	0.38
Operating Margin	-7.16	0.51	0.55
ROA	-51.93	< 0.005	< 0.005
ROE	0.03	0.01	-51.69
ROIC	0.01	< 0.005	-14.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.03	-46.17
Dividends QOQ	0.00	0.03	100.00
EBIT QOQ	0.13	-0.14	10.44
EPS QOQ	0.73	-0.54	-26.18
FCF QOQ	-4.21	0.44	-89.44
Revenue QOQ	0.09	-0.07	-14.33
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-192.38	< 0.005	-100.00
Days Sales Outstanding (DSO)	42.79	50.92	18.99
Inventory Turnover	-0.47	458855000.00	98084782809.72
Debt/Capitalization	0.76	0.75	-1.58
Quick Ratio	0.61	0.72	16.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	64.49	65.05	0.87
Cash	4.15	4.99	20.13
Capex	-11.63	-7.47	35.73
Free Cash Flow	-7.44	-4.13	44.47
Revenue	6.45	5.97	-7.56
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.36	0.43	20.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	38.51	44.46	15.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating